- Home
- GMM vs ABVC Comparison
GMM vs ABVC Comparison
Compare GMM & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMM
- ABVC
- Stock Information
- Founded
- GMM 2017
- ABVC 2015
- Country
- GMM China
- ABVC United States
- Employees
- GMM N/A
- ABVC N/A
- Industry
- GMM
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- GMM
- ABVC Health Care
- Exchange
- GMM Nasdaq
- ABVC Nasdaq
- Market Cap
- GMM 57.9M
- ABVC 52.1M
- IPO Year
- GMM 2023
- ABVC N/A
- Fundamental
- Price
- GMM $1.95
- ABVC $2.80
- Analyst Decision
- GMM
- ABVC
- Analyst Count
- GMM 0
- ABVC 0
- Target Price
- GMM N/A
- ABVC N/A
- AVG Volume (30 Days)
- GMM 23.9K
- ABVC 88.9K
- Earning Date
- GMM 08-18-2025
- ABVC 11-14-2025
- Dividend Yield
- GMM N/A
- ABVC N/A
- EPS Growth
- GMM N/A
- ABVC N/A
- EPS
- GMM 1.79
- ABVC N/A
- Revenue
- GMM $48,171,048.00
- ABVC $391,242.00
- Revenue This Year
- GMM N/A
- ABVC $735.18
- Revenue Next Year
- GMM N/A
- ABVC N/A
- P/E Ratio
- GMM $1.09
- ABVC N/A
- Revenue Growth
- GMM 41.74
- ABVC 186.84
- 52 Week Low
- GMM $1.69
- ABVC $0.40
- 52 Week High
- GMM $7.23
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- GMM 48.08
- ABVC 43.50
- Support Level
- GMM $1.83
- ABVC $2.75
- Resistance Level
- GMM $1.95
- ABVC $2.98
- Average True Range (ATR)
- GMM 0.09
- ABVC 0.13
- MACD
- GMM 0.01
- ABVC -0.02
- Stochastic Oscillator
- GMM 66.70
- ABVC 16.39
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.